Spatiotemporal changes of apolipoprotein E immunoreactivity and apolipoprotein E mRNA expression after transient middle cerebral artery occlusion in rat brain

Journal of Neuroscience Research

Volumn 73, Issue 4, 2003, Pages 545-556

  Kamada, Hiroshi ^a   Sato, Keiko ^a   Zhang, Wen Ri ^a   Omori, Nobuhiko ^a   Nagano, Isao ^a   Shoji, Mikio ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E; Brain ischemia; Rat

Indexed keywords

APOLIPOPROTEIN E; MESSENGER RNA; PROTEIN; PROTEIN ED1; PROTEIN NEUN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; MIDDLE CEREBRAL ARTERY; NERVE CELL; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; BRAIN ISCHEMIA; CELL COUNT; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAINING AND LABELING; TIME FACTORS;

EID: 0042673983     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10658     Document Type: Article

References (39)

1. Beffert U, Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J. 1998. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res Rev 27:119-142.
2. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. 1985. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501-1513.
3. Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke PJ, Ignatius MJ, Shooter EM. 1989. A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83:1015-1031.
4. Chait A, Heinecke J. 1994. Lipoprotein modification cellular mechanisms. Curr Opin Lipidol 5:365-370.
5. Damoiseaux JGMC, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. 1994. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83:140-147.
6. Han SH, Einstein G, Weisgraber KH, Strittmatter WJ, Saunders AM, Pericak-Vance M, Roses AD. Schmechel DE. 1994. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J Neuropathol Exp Neurol 53:535-544.
7. Handelmann GE, Boyles JK, Weisgraber KH, Mahley RW, Pitas RE. 1992. Effects of apolipoprotein, β-very low density lipoproteins, and cholesterol on the extension of neuritis by dorsal ganglion neurons, in vitro. J Lipid Res 33:1677-1688.
8. Horsburgh K, Nicoll JAR. 1996. Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischemia in the rat. Neuropathol Appl Neurobiol 22:342-349.
9. Horsburgh K, Kelly S, McCulloch J, Higgins GA, Roses AD, Nicoll JAR. 1999. Increased neuronal damage in apolipoprotein E-deficient mice following global ischemia. Neuroreport 10:837-841.
10. Horsburgh K, McCulloch J, Nilsen M, McCracken E, Large C, Roses AD, Nicoll JA. 2000. Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice. J Cereb Blood Flow Metab 20:458-462.
11. Igeta Y, Kawarabayashi T, Sato M, Yamada N, Matsubara E, Ishiguro K, Kanai M, Tomidokoro Y, Osuga J, Okamoto K, Hirai S, Shoji M. 1997. Apolipoprotein E accumulates with the progression of Aβ deposition in transgenic mice. J Neuropathol Exp Neurol 56:1228-1235.
12. Ignatius MJ, Gebicke-Harter PJ, Skene JHP, Shilling JW, Weisgraber KH, Mahley RW, Shooter EM. 1986. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 83:1125-1129.
13. Ishimaru H, Ishikawa K, Ohe Y, Takahashi A, Maruyama Y. 1996. Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus. Brain Res 709:155-162.
14. Kida E, Pluta R, Lossinsky AS, Golabek AA, Choi NH, Wisniewski HM, Mossakowski MJ. 1995. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. Extracellular and intracellular accumulation of apolipoprotein E and J in the brain. Brain Res 674:341-346.
15. Kitagawa H, Sasaki C, Sakai K, Mori A, Mitsumoto Y, Mori T, Fukuchi Y, Setoguchi Y, Abe K. 1999. Adenovirus-mediated gene transfer of GDNF prevents ischemic brain injury after transient MCA occlusion in rats. J Cereb Blood Flow Metab 19:1336-1344.
16. Kitagawa K, Matsumoto M, Kuwabara K, Ohtsuki T, Hori M. 2001. Delayed, but marked, expression of apolipoprotein E is involved in tissue clearance after cerebral infarction. J Cereb Blood Flow Metab 21:1199-1207.
17. Kitagawa K, Matsumoto M, Kuwabara K, Takasawa K, Tanaka S, Sasaki T, Matsushita K, Ohtsuki T, Yanagihara T, Hori M. 2002. Protective effect of apolipoprotein E against ischemic neuronal injury is mediated through antioxidant action. J Neurosci Res 68:226-232.
18. Kudo M, Nagayama K. 1988. Light and electron microscopic study of lipid accumulation along marigins of experimental cerebral infarcts in rats. Stroke 19:1544-1549.
19. Larkine L, Khachigian LM, Jessup W. 2000. Regulation of apolipoprotein E production in macrophages. Int J Mol Med 6:253-258.
20. Laskowitz DT, Mattew WD, Bennett ER, Schmechel DE, Herbstreith MH, Goel S. 1998. Apoliporotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport 9:615-618.
21. Lehrmann E, Kiefer R, Christensen T, Toyka KV, Zimmer J, Diemer NH, Hartung HP, Finsen B. 1998. Microglia and macrophages are major sources of locally produced transforming growth factor-beta1 after transient middle cerebral artery occlusion in rats. Glia 24:437-448.
22. Mahley RW. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
23. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW. 2001. CNS synaptogenisis promoted by glia-derived cholesterol. Science 294:1354-1313.
24. Mazzone T, Basheeruddin K, Poulos C. 1989. Regulation of macrophage apolipoprotein E expression by cholesterol. J Lipid Res 30:1055-1064.
25. Miyata M, Smith JD. 1996. Apolipoprotein E allele-specific antioxidant activity and effects of cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet 14:55-61.
26. Nathan BP, Bellosta S, Sanan DA, Weissgraber KH, Mahley RW, Pitas RE. 1994. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 264:850-852.
27. Page KJ, Hollister D, Hyman BT. 1998. Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization study. Neuroscience 85:1161-1171.
28. Pitas RE, Boyles JK, Lee SH, Hui D, Wisbraber KH. 1987. Lipoproteins and their receptors in the central nervous system. J Biol Chem 262:14352-14360.
29. Poirier J, Baccichet A, Dea D, Gauthier S. 1993. Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience 55:81-90.
30. Rosenfeld ME, Butler S, Ord UA, Lipton BA, Dyer CA, Curtiss LK, Palinski W, Witztum JL. 1993. Abundant expression of apolipoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb 13:1382-1389.
31. Rouis M, Nigon F, Eggerman T, Brewer H Jr, Chapman M. 1990. Apolipoprotein E expression by human monocyte-derived macrophages. Modulation by opsonised zymosan and cholesterol. Eur J Biochem 189:447-453.
32. Sato K, Kashihara K, Morimoto K, Hayabara T. 1996. Regional increases in brain-derived neurotrophic factor and nerve growth factor in mRNAs during amygdaloid kindling, but not in acidic and basic fibroblast growth factor mRNAs. Epilepsia 37:6-14.
33. Sheng H, Laskowitz DT, Mackensen B, Kudo M, Pealstein RD, Warner DS. 1999. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. Stroke 30:1118-1124.
34. Shimano H, Fukazawa C, Shibasaki Y, Mori N, Gotoda T, Harada K, Shimada M, Yamada N, Yazaki Y. 1991. The effect of apoE secretion on lipoprotein uptake in transfected cells. Biochim Biophys Acta 1086:245-254.
35. Stroemer RP, Kent TA, Hulsebosch CE. 1995. Neocortical neural sprouting synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 26:2135-2144.
36. Trieu VN, Uckun FM. 2000. Apolipoprotein E and apolipoprotein D expression in a murine model of singlet oxygen-induced cerebral stroke. Biochem Biophys Res Commun 268:835-841.
37. Van Beek J, Chan P, Bernaudin M, Petit E, Mackenzie ET, Fontaine M. 2000. Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse. Glia 31:39-50.
38. White F, Nicoll JAR, Horsburgh. 2001. Alterations in ApoE and ApoJ in relation to degeneration and regulation in a mouse model of entorhinal cortex lesion. Exp Neurology 169:307-318.
39. Yamashita K, Vogel P, Fritze K, Back T, Hossmann KA, Wiessner C. 1996. Monitoring the temporal cerebral ischemia using in situ hybridization to GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists. Brain Res 735:285-229.